Sj. Shankland et Jw. Scholey, EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 DURING DIABETIC RENALHYPERTROPHY, Kidney international, 46(2), 1994, pp. 430-442
Expression of transforming growth factor-beta 1 during diabetic renal
hypertrophy. Experimental type I diabetes mellitus is characterized by
an early increase in kidney weight and glomerular volume, but changes
in gene expression accompanying diabetic renal growth have not been f
ully elucidated. In the current study, total RNA was extracted from re
nal cortex and isolated glomeruli of streptozotocin-induced diabetic r
ats 24 hours, 48 hours, 96 hours, one and two weeks after the onset of
hyperglycemia (blood glucose >15 mmol/liter), insulin-treated diabeti
c rats (blood glucose <6.0 mmol/liter), and normal rats. RNA samples w
ere reverse transcribed (RT) and subjected to polymerase chain reactio
n (PCR) amplication with specific 5' and 3' primers for rat transformi
ng growth factor (TGF-beta 1) and beta-actin. RT-PCR analysis revealed
that glomerular TGF-beta 1 mRNA levels increased relative to beta-act
in as early as 24 hours after the onset of hyperglycemia, reaching a p
lateau after 96 hours that was sustained at one and two weeks. In cort
ical samples, TGF-beta 1 mRNA levels increased less abruptly, reaching
a peak one week after the onset of hyperglycemia. Intensive insulin t
reatment to normalize blood glucose levels attenuated the rise in glom
erular and renal cortical TGF-beta 1 mRNA. Cryostat sections of rat ki
dneys were immunostained for TGF-beta 1 utilizing a polyclonal anti-po
rcine TGF-beta 1 antibody and semiquantitative scoring of TGF-beta 1 i
mmunostaining revealed a twofold increase in diabetic glomeruli after
two weeks compared to normal glomeruli. Increased segmental immunostai
ning for TGF-beta 1 was also evident in cortical tubules of diabetic r
ats. These studies establish that TGF-beta 1 expression in the kidney
increases during the phase of rapid renal hypertrophy in diabetic rats
. Normalization of blood glucose levels with insulin treatment attenua
tes the increase in TGF-beta 1 expression.